| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 67028 |
Intravitreal injection of a pharmacologic agent |
8,922 |
8,812 |
$516K |
| J9035 |
Injection, bevacizumab, 10 mg |
6,205 |
6,138 |
$335K |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
281 |
279 |
$334K |
| 92134 |
|
12,786 |
12,583 |
$259K |
| J0178 |
Injection, aflibercept, 1 mg |
188 |
188 |
$222K |
| Q5128 |
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg |
196 |
196 |
$156K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
3,298 |
3,271 |
$151K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,357 |
1,345 |
$105K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
789 |
788 |
$68K |
| 92235 |
|
225 |
225 |
$17K |
| 67228 |
|
13 |
13 |
$3K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
15 |
15 |
$1K |